Avera Receives National Innovator Award
Avera McKennan Hospital & University Health Center, Avera Cancer Institute has been awarded the 2013 Association of Community Cancer Centers (ACCC) Innovator Award, sponsored by GE Healthcare. Avera McKennan is the only hospital in the Midwest to receive this award.
This national awards program honors ACCC members that have exhibited forward-thinking strategic planning and developed pioneering programs and replicable models in cancer patient care. The Avera Cancer Institute was awarded for its creation of the Rural Chemotherapy Project in order to ensure consistent access to quality care for patients in rural areas. This quality improvement project was established to implement unified chemotherapy administration standards across 45 sites—both within and outside of the Avera system. The goal was to establish guidelines and standards of practice in all rural sites outside of the Avera Cancer Institute. To accomplish this, Avera’s Rural Chemotherapy Committee created a process that included a mandatory educational webinar and completion of a chemotherapy preparation and administration checklist for all sites.
“The Avera Cancer Institute has worked to develop patient-centered, high quality patient care that meets or exceeds national standards, and it was our goal to share these best practices throughout our region. Avera excels at providing quality care, nearby home, and we feel like this project helps us reach this goal, especially at our rural locations,” said Crystal Enstad, Infusion Center Manager at Avera Cancer Institute in Sioux Falls.
ACCC 2013 Innovator Award recipients will be recognized at the ACCC 30th National Oncology Conference in Boston, Mass., Oct. 2-5. These innovators will share their creative solutions and outstanding programs with meeting attendees. Both ACCC and GE Healthcare will highlight these innovative programs to oncology care providers as well as to the broader health care community across the country. ACCC is the leading national multidisciplinary organization that sets the standard for quality care for patients with cancer.